Reference
Andrus JK, et al. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses. Vaccine 33 (Suppl. 1): A2-A3, 7 May 2015
Rights and permissions
About this article
Cite this article
Key updates to vaccination cost-effectiveness analyses. PharmacoEcon Outcomes News 727, 20 (2015). https://doi.org/10.1007/s40274-015-2104-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2104-z